Yet, there is growing evidence that missense TP53 mutations may often also confer upon the mutant p53 (mutp53) proteins oncogenic gain-of-function (GOF) properties, which can actively contribute to cancer-related processes4–9. The gene discussed is TP53; the disease is cancer.